Literature DB >> 7705195

Relationship between obesity and concordance rate for type 2 (non-insulin-dependent) diabetes mellitus among twins.

A Matsuda1, T Kuzuya.   

Abstract

In order to analyse the relationship of genetic factors and the role of obesity in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus, we compared body mass index (BMI) and other parameters in 71 monozygotic and 17 dizygotic twins (MZT and DZT) with Type 2 diabetes, and analysed the relationship of maximal BMI in the past (max BMI) with the concordance and discordance for diabetes. Data were collected by mail from the members of the Japan Diabetes Society. Concordance rate for diabetes was higher in MZT than in DZT (72% vs. 41%, P = 0.017). Concordance rate in MZT varied in relation to the max BMI of the index twins who developed diabetes earlier. It was higher in non-obese and slightly obese groups (82% and 80% for those with max BMI < 24 and 24-27.9, respectively) than in obese group (36%, max BMI > or = 28) (P = 0.003). In MZT, diabetic twins of discordant pairs were significantly more obese at the survey and in the past than index twins of concordant pairs (mean BMI: 23.9 vs. 21.7, P = 0.007; mean max BMI, 27.7 vs. 24.3, P = 0.001). A similar tendency of differences in BMI was also observed in DZT. Intrapair comparison in discordant MZT and DZT pairs showed that diabetic twins were more obese than non-diabetic cotwins (mean max BMI, 27.7 vs. 24.7, P = 0.004 for MZT; and 27.3 vs. 23.9, P = 0.002 for DZT). In concordant DZT pairs, index twins with earlier onset of diabetes had been less obese than cotwins (mean max BMI, 23.6 vs. 26.0, P = 0.004). In conclusion, the comparison of the max BMI in twins suggests that the degree of diabetogenic role of obesity varies in heterogeneous genetic background. The index twins of discordant pairs had been more obese than those of concordant pairs, suggesting that obesity plays a more important role in those with weaker genetic susceptibility for diabetes.

Entities:  

Mesh:

Year:  1994        PMID: 7705195     DOI: 10.1016/0168-8227(94)90151-1

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China.

Authors:  Qi Pei; Qiong Huang; Guo-ping Yang; Ying-chun Zhao; Ji-ye Yin; Min Song; Yi Zheng; Zhao-hui Mo; Hong-hao Zhou; Zhao-qian Liu
Journal:  Acta Pharmacol Sin       Date:  2012-11-12       Impact factor: 6.150

Review 2.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

3.  Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons.

Authors:  M van Hoek; T W van Herpt; A Dehghan; A Hofman; A G Lieverse; C M van Duijn; J C M Witteman; E J G Sijbrands
Journal:  Diabetologia       Date:  2011-03-04       Impact factor: 10.122

4.  Family history, diabetes, and other demographic and risk factors among participants of the National Health and Nutrition Examination Survey 1999-2002.

Authors:  Ann M Annis; Mark S Caulder; Michelle L Cook; Debra Duquette
Journal:  Prev Chronic Dis       Date:  2005-03-15       Impact factor: 2.830

Review 5.  Alternatives to Insulin for the Regulation of Blood Sugar Levels in Type 2 Diabetes.

Authors:  Stephen C Bondy; Meixia Wu; Kedar N Prasad
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

6.  Mammalian NPC1 genes may undergo positive selection and human polymorphisms associate with type 2 diabetes.

Authors:  Nasser M Al-Daghri; Rachele Cagliani; Diego Forni; Majed S Alokail; Uberto Pozzoli; Khalid M Alkharfy; Shaun Sabico; Mario Clerici; Manuela Sironi
Journal:  BMC Med       Date:  2012-11-15       Impact factor: 8.775

7.  Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism.

Authors:  Mandy van Hoek; Janneke G Langendonk; Susanne R de Rooij; Eric J G Sijbrands; Tessa J Roseboom
Journal:  Diabetes       Date:  2009-03-03       Impact factor: 9.461

Review 8.  An Overview of Herbal Products and Secondary Metabolites Used for Management of Type Two Diabetes.

Authors:  Ajda Ota; Nataša P Ulrih
Journal:  Front Pharmacol       Date:  2017-07-06       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.